Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic.
COVID-19
Children
Diabetic ketoacidosis
Type 1 Diabetes
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
09 Feb 2022
09 Feb 2022
Historique:
received:
07
09
2021
accepted:
22
01
2022
entrez:
10
2
2022
pubmed:
11
2
2022
medline:
12
2
2022
Statut:
epublish
Résumé
The COVID-19 pandemic period is having a strong impact on the management of diabetes as well as other chronic diseases as shown by the most severe clinical presentation at onset. The aim of this study was to evaluate the severity of diabetic ketoacidosis (DKA) in youth with newly diagnosed type 1 diabetes in "Santissima Annunziata Hospital" (Chieti, Italy) during COVID-19 pandemic in comparison to the five previous years. A retrospective population-based incidence study was performed. Data were obtained from hospital records of 172 patients with new onset type 1 diabetes divided into two groups according to the diagnosis: Group I, between January 2015 and February 2020; Group II, between March 2020 and April 2021. Data regarding anthropometric, socio-economic and laboratory test were analyzed. DKA (pH < 7.30) and different severity of the disease (severe pH < 7.10; moderate pH < 7.20, mild pH < 7.30) were evaluated. A Spearman correlation between pH values and the main variables of interest was performed. DKA frequency was increased by 19 percentage in Group II compared to Group I (55% vs 36%; P = 0.03) with a significant increased risk of severe DKA cases compared to the previous five years (severe DKA 22.5% vs. 8.4%, P = 0.01). pH values were significantly related with HbA1c, blood glucose and c-peptide values in all groups. In addition, in Group II but not in Group I, pH values correlated with Triglycerides and TG/HDL cholesterol ratio. During COVID-19 pandemic the risk of more severe clinical presentation of type 1 diabetes at onset is increased. The correlation with lipid profile might suppose an additional effect of lifestyle changes beside the delay in the diagnosis. Modifications of health care system need to be implemented during this peculiar situation in order to avoid such a relevant complication at onset.
Sections du résumé
BACKGROUND
BACKGROUND
The COVID-19 pandemic period is having a strong impact on the management of diabetes as well as other chronic diseases as shown by the most severe clinical presentation at onset. The aim of this study was to evaluate the severity of diabetic ketoacidosis (DKA) in youth with newly diagnosed type 1 diabetes in "Santissima Annunziata Hospital" (Chieti, Italy) during COVID-19 pandemic in comparison to the five previous years.
METHODS
METHODS
A retrospective population-based incidence study was performed. Data were obtained from hospital records of 172 patients with new onset type 1 diabetes divided into two groups according to the diagnosis: Group I, between January 2015 and February 2020; Group II, between March 2020 and April 2021. Data regarding anthropometric, socio-economic and laboratory test were analyzed. DKA (pH < 7.30) and different severity of the disease (severe pH < 7.10; moderate pH < 7.20, mild pH < 7.30) were evaluated. A Spearman correlation between pH values and the main variables of interest was performed.
RESULTS
RESULTS
DKA frequency was increased by 19 percentage in Group II compared to Group I (55% vs 36%; P = 0.03) with a significant increased risk of severe DKA cases compared to the previous five years (severe DKA 22.5% vs. 8.4%, P = 0.01). pH values were significantly related with HbA1c, blood glucose and c-peptide values in all groups. In addition, in Group II but not in Group I, pH values correlated with Triglycerides and TG/HDL cholesterol ratio.
CONCLUSIONS
CONCLUSIONS
During COVID-19 pandemic the risk of more severe clinical presentation of type 1 diabetes at onset is increased. The correlation with lipid profile might suppose an additional effect of lifestyle changes beside the delay in the diagnosis. Modifications of health care system need to be implemented during this peculiar situation in order to avoid such a relevant complication at onset.
Identifiants
pubmed: 35139895
doi: 10.1186/s13052-022-01223-8
pii: 10.1186/s13052-022-01223-8
pmc: PMC8827260
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
26Informations de copyright
© 2022. The Author(s).
Références
Diabetologia. 2020 Aug;63(8):1530-1541
pubmed: 32382815
Diabetologia. 2012 Nov;55(11):2878-94
pubmed: 22933123
Pediatr Endocrinol Diabetes Metab. 2020;26(4):167-175
pubmed: 33554490
Pediatr Diabetes. 2019 Mar;20(2):172-179
pubmed: 30556249
Diabetes Care. 2011 Aug;34(8):1869-74
pubmed: 21730284
Diabet Med. 2006 Aug;23(8):857-66
pubmed: 16911623
Front Pediatr. 2020 Apr 30;8:213
pubmed: 32426310
Pediatr Diabetes. 2021 Mar;22(2):202-206
pubmed: 33205546
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Diabetologia. 2008 May;51(5):846-52
pubmed: 18373080
Diabetologia. 2015 May;58(5):980-7
pubmed: 25660258
J Sport Health Sci. 2020 Jul;9(4):302-312
pubmed: 32454174
Arch Dis Child. 2020 Jul;105(7):704-706
pubmed: 32461213
Diabetes Res Clin Pract. 2021 May;175:108838
pubmed: 33901625
Pediatrics. 2014 Apr;133(4):e938-45
pubmed: 24685959
BMJ Paediatr Open. 2020 Nov 2;4(1):e000884
pubmed: 34192183
J Pediatr. 2020 Aug;223:197-198
pubmed: 32437758
Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177
pubmed: 29900641
JAMA. 2014 Feb 26;311(8):806-14
pubmed: 24570244
Clin Nutr. 2018 Aug;37(4):1423-1429
pubmed: 28673690
J Pediatr. 2010 Mar;156(3):472-7
pubmed: 19962155
Diabetes Res Clin Pract. 2019 Nov;157:107842
pubmed: 31518658
Pediatr Diabetes. 2012 Dec;13(8):647-51
pubmed: 22816992
Eur J Clin Nutr. 2002 Feb;56(2):171-80
pubmed: 11857051
Diabetes Care. 2007 Apr;30(4):e12
pubmed: 17392527
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1633-1644
pubmed: 32771260
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Pediatr Clin North Am. 2015 Aug;62(4):857-71
pubmed: 26210621
Diabetologia. 2010 Dec;53(12):2611-20
pubmed: 20871974
Diabetes Care. 2009 May;32(5):769-73
pubmed: 19407074
Lipids Health Dis. 2020 Mar 4;19(1):33
pubmed: 32131838
Diabetes Care. 1999 Jan;22(1):7-9
pubmed: 10333896
Diabetes Care. 2020 Nov;43(11):2870-2872
pubmed: 32778554
Arch Med Res. 2004 Mar-Apr;35(2):134-40
pubmed: 15010193
JAMA. 2014 May 7;311(17):1778-86
pubmed: 24794371
J Pediatr. 2014 May;164(5 Suppl):S1-14.e6
pubmed: 24731744